Mechanistically, the combination of FA and MLT might alleviate hepatic ERS by activating AMPK, thereby enhancing PPARγ-mediated lipolysis of LD, ultimately reducing lipid accumulation and preventing hepatic steatosis (Figure 9). This evidence concerns the gene PPARG and fatty liver disease.